scholarly article | Q13442814 |
P2093 | author name string | Sheng-You Huang | |
Xiaoqin Zou | |||
P2860 | cites work | A Simplex Method for Function Minimization | Q55954356 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 399-421 | |
P577 | publication date | 2007-02-01 | |
P1433 | published in | Proteins | Q7251514 |
P1476 | title | Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. | |
P478 | volume | 66 |
Q39807158 | 2,4-Diamino-5-(2'-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition |
Q51297155 | A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs. |
Q43181588 | A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE). |
Q55432485 | A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model. |
Q28541718 | A structure-based model for predicting serum albumin binding |
Q34402706 | ALiBERO: evolving a team of complementary pocket conformations rather than a single leader |
Q39062782 | Addressing recent docking challenges: A hybrid strategy to integrate template-based and free protein-protein docking. |
Q34377911 | Advances and challenges in protein-ligand docking |
Q34616682 | Advances in fragment-based drug discovery platforms |
Q36838120 | An improved relaxed complex scheme for receptor flexibility in computer-aided drug design |
Q34744590 | An inverse docking approach for identifying new potential anti-cancer targets. |
Q34019272 | Application of NMR and molecular docking in structure-based drug discovery |
Q33940712 | Atomic basis of CRM1-cargo recognition, release and inhibition |
Q41886859 | Automated large-scale file preparation, docking, and scoring: evaluation of ITScore and STScore using the 2012 Community Structure-Activity Resource benchmark |
Q30578152 | Automatic design of decision-tree induction algorithms tailored to flexible-receptor docking data. |
Q41043727 | BP-Dock: a flexible docking scheme for exploring protein-ligand interactions based on unbound structures |
Q50593408 | Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO Receptor. |
Q58719254 | Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview |
Q55518690 | COACH-D: improved protein-ligand binding sites prediction with refined ligand-binding poses through molecular docking. |
Q30387722 | CSAR 2014: A Benchmark Exercise Using Unpublished Data from Pharma |
Q27702220 | CSAR Benchmark Exercise 2013: Evaluation of Results from a Combined Computational Protein Design, Docking, and Scoring/Ranking Challenge |
Q28484330 | Can the energy gap in the protein-ligand binding energy landscape be used as a descriptor in virtual ligand screening? |
Q35206344 | Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design. |
Q33449492 | Closing the side-chain gap in protein loop modeling |
Q92178374 | Comparison of Data Fusion Methods as Consensus Scores for Ensemble Docking |
Q39743323 | Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design |
Q34578072 | Computational docking of antibody-antigen complexes, opportunities and pitfalls illustrated by influenza hemagglutinin. |
Q26777448 | Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors |
Q34127928 | Computational fragment-based screening using RosettaLigand: the SAMPL3 challenge |
Q37158502 | Computational methods of studying the binding of toxins from venomous animals to biological ion channels: theory and applications |
Q34519388 | Computer-aided drug-discovery techniques that account for receptor flexibility |
Q34440071 | Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors |
Q41382543 | Consistent improvement of cross-docking results using binding site ensembles generated with elastic network normal modes |
Q24616986 | Constructing ensembles for intrinsically disordered proteins |
Q38672355 | Construction and test of ligand decoy sets using MDock: community structure-activity resource benchmarks for binding mode prediction |
Q30763126 | Context-based preprocessing of molecular docking data |
Q36447801 | DARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction Sites |
Q35172317 | Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase. |
Q61805653 | Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling |
Q36280727 | Discovery of Novel ROCK1 Inhibitors via Integrated Virtual Screening Strategy and Bioassays |
Q37344732 | Discovery of Staphylococcus aureus sortase A inhibitors using virtual screening and the relaxed complex scheme |
Q33635679 | Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structures |
Q30607323 | Docking challenge: protein sampling and molecular docking performance |
Q55341853 | Docking-based inverse virtual screening: methods, applications, and challenges. |
Q35926542 | Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology |
Q47139697 | Efficient conformational ensemble generation of protein-bound peptides |
Q51532081 | Efficient inclusion of receptor flexibility in grid-based protein-ligand docking. |
Q36420334 | Efficient molecular docking of NMR structures: application to HIV-1 protease |
Q84037024 | Elastic potential grids: accurate and efficient representation of intermolecular interactions for fully flexible docking |
Q34908421 | Emerging methods for ensemble-based virtual screening |
Q38583453 | Enhanced molecular dynamics sampling of drug target conformations |
Q42320200 | Enhancing Virtual Screening Performance of Protein Kinases with Molecular Dynamics Simulations |
Q47750111 | Ensemble docking to difficult targets in early-stage drug discovery: Methodology and application to fibroblast growth factor 23. |
Q33757270 | Evaluating docking methods for prediction of binding affinities of small molecules to the G protein betagamma subunits |
Q35969861 | Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform. |
Q51438298 | Exploring c-Met kinase flexibility by sampling and clustering its conformational space. |
Q33327065 | Exploring structural variability in X-ray crystallographic models using protein local optimization by torsion-angle sampling |
Q41383381 | Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives. |
Q37215648 | FINDSITE: a combined evolution/structure-based approach to protein function prediction |
Q34173497 | FReDoWS: a method to automate molecular docking simulations with explicit receptor flexibility and snapshots selection. |
Q24650066 | Flexible ligand docking to multiple receptor conformations: a practical alternative |
Q43153980 | Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking |
Q35074986 | Fragment-based Shape Signatures: a new tool for virtual screening and drug discovery |
Q34690000 | Fragment-based lead discovery on G-protein-coupled receptors |
Q51668649 | HIV-1 TAR RNA Spontaneously Undergoes Relevant Apo-to-Holo Conformational Transitions in Molecular Dynamics and Constrained Geometrical Simulations |
Q55518736 | HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm. |
Q56984187 | How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysis |
Q64059641 | Hybrid approach to sieve out natural compounds against dual targets in Alzheimer's Disease |
Q24656051 | Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach |
Q41490277 | Importance of protein flexibility in ranking inhibitor affinities: modeling the binding mechanisms of piperidine carboxamides as Type I1/2 ALK inhibitors |
Q38698230 | Improving binding mode and binding affinity predictions of docking by ligand-based search of protein conformations: evaluation in D3R grand challenge 2015. |
Q80642884 | Improving database enrichment through ensemble docking |
Q30391029 | In Pursuit of Fully Flexible Protein-Ligand Docking: Modeling the Bilateral Mechanism of Binding |
Q28546330 | In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug |
Q35419556 | Inclusion of solvation and entropy in the knowledge-based scoring function for protein-ligand interactions |
Q37565089 | Inclusion of the orientational entropic effect and low-resolution experimental information for protein-protein docking in Critical Assessment of PRedicted Interactions (CAPRI). |
Q40526825 | Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase. |
Q28544409 | Isolation, purification and molecular mechanism of a peanut protein-derived ACE-inhibitory peptide |
Q42361137 | Iterative Knowledge-Based Scoring Functions Derived from Rigid and Flexible Decoy Structures: Evaluation with the 2013 and 2014 CSAR Benchmarks |
Q52597351 | KRDS: a web server for evaluating drug resistance mutations in kinases by molecular docking. |
Q36938240 | Knowledge-Based Methods To Train and Optimize Virtual Screening Ensembles |
Q47414331 | Lessons learned in induced fit docking and metadynamics in the Drug Design Data Resource Grand Challenge 2. |
Q34188650 | MDockPP: A hierarchical approach for protein-protein docking and its application to CAPRI rounds 15-19 |
Q51590304 | Microscopic Characterization of Membrane Transporter Function by In Silico Modeling and Simulation. |
Q30409794 | Minimal ensembles of side chain conformers for modeling protein-protein interactions |
Q33787280 | Mining flexible-receptor docking experiments to select promising protein receptor snapshots |
Q51898453 | Modeling and selection of flexible proteins for structure-based drug design: backbone and side chain movements in p38 MAPK. |
Q41089717 | Modelling proteins' hidden conformations to predict antibiotic resistance |
Q33459531 | Modelling substrate specificity and enantioselectivity for lipases and esterases by substrate-imprinted docking |
Q47362097 | Molecular Modeling of Multidrug Properties of Resistance Nodulation Division (RND) Transporters. |
Q37378641 | Molecular modeling of the heterodimer of human CFTR's nucleotide-binding domains using a protein-protein docking approach |
Q30398315 | Monte Carlo replica-exchange based ensemble docking of protein conformations |
Q31132931 | New binding site conformations of the dengue virus NS3 protease accessed by molecular dynamics simulation. |
Q47788380 | Optimization of compound ranking for structure-based virtual ligand screening using an established FRED-Surflex consensus approach |
Q39513411 | PL-PatchSurfer2: Improved Local Surface Matching-Based Virtual Screening Method That Is Tolerant to Target and Ligand Structure Variation |
Q46066890 | POVME 3.0: Software for Mapping Binding Pocket Flexibility. |
Q51373396 | PRL-Dock: protein-ligand docking based on hydrogen bond matching and probabilistic relaxation labeling. |
Q47797655 | Performance of multiple docking and refinement methods in the pose prediction D3R prospective Grand Challenge 2016. |
Q38179927 | Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs |
Q35073109 | Predictive power of molecular dynamics receptor structures in virtual screening |
Q47584237 | ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research. |
Q39719414 | Protease Inhibitors in View of Peptide Substrate Databases |
Q31039692 | Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell |
Q26864013 | Protein flexibility in docking and surface mapping |
Q36788480 | Protein-ligand docking with multiple flexible side chains |
Q37304442 | Q-Dock: Low-resolution flexible ligand docking with pocket-specific threading restraints |
Q47314483 | RRDB: A comprehensive and nonredundant benchmark for RNA-RNA docking and scoring |
Q34460848 | ReFlexIn: a flexible receptor protein-ligand docking scheme evaluated on HIV-1 protease |
Q57975284 | Receptor flexibility in small-molecule docking calculations |
Q35586644 | Reduction of false positives in structure-based virtual screening when receptor plasticity is considered. |
Q47291097 | Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations |
Q55012557 | RosettaLigandEnsemble: A Small-Molecule Ensemble-Driven Docking Approach. |
Q38672424 | Scoring and lessons learned with the CSAR benchmark using an improved iterative knowledge-based scoring function |
Q42920364 | Scoring ensembles of docked protein:ligand interactions for virtual lead optimization |
Q28728561 | Software and resources for computational medicinal chemistry |
Q36568029 | Statistical analysis of EGFR structures' performance in virtual screening |
Q27311652 | Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies |
Q36477022 | Survey of public domain software for docking simulations and virtual screening. |
Q28478200 | Systematic exploitation of multiple receptor conformations for virtual ligand screening |
Q37240137 | Target flexibility: an emerging consideration in drug discovery and design |
Q37352130 | The HSP90 binding mode of a radicicol-like E-oxime determined by docking, binding free energy estimations, and NMR 15N chemical shifts |
Q45789568 | The assessment of computationally derived protein ensembles in protein-ligand docking. |
Q30383112 | Ultra-High-Throughput Structure-Based Virtual Screening for Small-Molecule Inhibitors of Protein-Protein Interactions. |
Q30379556 | Ultrafast protein structure-based virtual screening with Panther. |
Q38594557 | Understanding the challenges of protein flexibility in drug design. |
Q39766336 | Visualizing ensembles in structural biology |
Search more.